David Shaw’s Jazz Pharmaceuticals JAZZ Stock Holding History

David Shaw’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,000	Closed	-$1.33M	–	4975
2022 Q3	$1.33M	Hold	10,000	–	–	﹤0.01%	3362
2022 Q2	$1.56M	Hold	10,000	–	–	﹤0.01%	3287
2022 Q1	$1.56M	Sell	10,000 -24,620	-71%	-$3.57M	﹤0.01%	3545
2021 Q4	$4.41M	Buy	34,620 +10,000	+41%	+$1.31M	﹤0.01%	2521
2021 Q3	$3.21M	Buy	+24,620	New	+$3.72M	﹤0.01%	2561
2021 Q2	–	Sell	-10,000	Closed	-$1.64M	–	4873
2021 Q1	$1.64M	Buy	+10,000	New	+$1.65M	﹤0.01%	2752
2020 Q4	–	Sell	-21,200	Closed	-$3.02M	–	4026
2020 Q3	$3.02M	Sell	21,200 -11,000	-34%	-$1.36M	﹤0.01%	2065
2020 Q2	$3.55M	Sell	32,200 -13,100	-29%	-$1.45M	﹤0.01%	1929
2020 Q1	$4.52M	Buy	45,300 +11,500	+34%	+$1.49M	0.01%	1544
2019 Q4	$5.05M	Buy	+33,800	New	+$4.6M	0.01%	1727
2017 Q2	–	Sell	-17,000	Closed	-$2.47M	–	3448
2017 Q1	$2.47M	Sell	17,000 -6,800	-29%	-$886K	﹤0.01%	1707
2016 Q4	$2.6M	Buy	23,800 +3,800	+19%	+$423K	﹤0.01%	1794
2016 Q3	$2.43M	Hold	20,000	–	–	﹤0.01%	1774
2016 Q2	$2.83M	Hold	20,000	–	–	0.01%	1681
2016 Q1	$2.61M	Hold	20,000	–	–	﹤0.01%	1698
2015 Q4	$2.81M	Buy	20,000 +10,000	+100%	+$1.39M	﹤0.01%	1868
2015 Q3	$1.33M	Buy	+10,000	New	+$1.72M	﹤0.01%	2407

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

David Shaw's JAZZ Position: Q2 2026 in Review

David Shaw reduced its Jazz Pharmaceuticals (JAZZ) stake by 71% in Q2 2026, selling an estimated $46.2M and leaving 87,075 shares worth $21M. The position accounts for 0.01% of the portfolio, ranked #1260.

David Shaw first reported a position in JAZZ in Q2 2013 and has held it in 41 quarters since. The position peaked at $56.4M in Q1 2026. 640 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

David Shaw held 87,075 shares of Jazz Pharmaceuticals worth $21M as of Q2 2026.
David Shaw sold 211,015 Jazz Pharmaceuticals shares in Q2 2026, an estimated $46.2M.
Jazz Pharmaceuticals made up 0.01% of David Shaw's portfolio in Q2 2026, its #1260 holding.
David Shaw first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 41 quarters since.
David Shaw's Jazz Pharmaceuticals position peaked at $56.4M in Q1 2026.
640 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.